New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

Huntington’s patients face cognitive, psychiatric, and physical decline as government support and cure remain elusive.

Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable ...

Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are among the most ...

Researchers led by the nonprofit 4YouandMe and Mount Sinai want to identify second-site suppressor mutations as drug targets ...

DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years in law enforcement, so don't even ask!" However, with all due respect to law ...

Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could top out at $2 ...

Rap icon Eminem reveals that a near-fatal drug overdose was the wake-up call that finally inspired him to get sober after ...

A community walk bringing awareness for Huntington’s Disease is back in Eau Claire for their ninth straight year. As part of ...

The Wisconsin Chapter of the Huntington’s Disease Society of America will be hosting the 2025 HDSA Madison Team Hope Walk on ...